Contents

Current Medicinal Chemistry, Volume 10 - Number 12

Preface (Hot Topic: Iron Chelation and Human Diseases Guest Editor: Regis Leung-Toung)

, 10(12): i

Regis Leung-Toung


DOI: 10.2174/0929867033457575




Iron Chelator Research: Past, Present, and Future

, 10(12): 983 - 995

Tim F. Tam, Regis Leung-Toung, Wanren Li, Yingsheng Wang, Khashayar Karimian and Michael Spino


DOI: 10.2174/0929867033457593




An Overview of Iron Metabolism: Molecular and Cellular Criteria for the Selection of Iron Chelators

, 10(12): 997 - 1004

Robert R. Crichton and Roberta J. Ward


DOI: 10.2174/0929867033457566




The HAG Mechanism: A Molecular Rationale For The Therapeutic Application Of Iron Chelators In Human Diseases Involving the 2-Oxoacid Utilizing Dioxygenases

, 10(12): 1005 - 1019

Hartmut M. Hanauske-Abel and Anthony M. Popowicz


DOI: 10.2174/0929867033457601




The Role of Iron Chelation in Cancer Therapy

, 10(12): 1021 - 1034

Joan L. Buss, Frank M. Torti and Suzy V. Torti


DOI: 10.2174/0929867033457638




Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators

, 10(12): 1035 - 1049

D. B. Lovejoy and D. R. Richardson


DOI: 10.2174/0929867033457557




Emerging Understanding of the Advantage of Small Molecules such as Hydroxypyridinones in the Treatment of Iron Overload

, 10(12): 1051 - 1064

Robert C. Hider and Zu D. Liu


DOI: 10.2174/0929867033457629




Development of Tridentate Iron Chelators: From Desferrithiocin to ICL670

, 10(12): 1065 - 1076

Hanspeter Nick, Pierre Acklin, Rene Lattmann, Peter Buehlmayer, Suzanne Hauffe, Joachim Schupp and Daniele Alberti


DOI: 10.2174/0929867033457610




Hydroxyquinolines as Iron Chelators

, 10(12): 1077 - 1084

J.- L. Pierre, P. Baret and G. Serratrice


DOI: 10.2174/0929867033457584




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science